Close Menu

NEW YORK (GenomeWeb) – Novogene said this week that the Tianjin Novogene Med Lab, a next-generation sequencing clinical lab for genomic testing, has received renewed CAP accreditation. Tianjin Novogene Med Lab was founded in June 2014, and was approved by the Municipal Health and Family Planning Commission in December 2014 for the application of clinical gene amplification technology. The lab first received CAP accreditation in February 2017.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.